Becker Daniel J.
Transaction: 06/17/2026
BUY
Change
+51,000
Price
$3.62
Filing
06/22/2026
Type
BUY
Zura Bio Limited
ZURA • Biotechnology
$6.15
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$779.84M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 9.05Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:53 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.15
Change0.00%
Shares Out126.80M
Market Cap$779.84M
Enterprise Value$574.71M
52W Range1.64 - 7.44
Beta-0.04
P/E-9.10
P/B3.96
P/FCF-10.05
EV/EBITDA-6.48
EV/FCF-7.40
Price$6.15
Change0.00%
Shares Out126.80M
Market Cap$779.84M
Enterprise Value$574.71M
52W Range1.64 - 7.44
Beta-0.04
P/E-9.10
P/B3.96
P/FCF-10.05
EV/EBITDA-6.48
EV/FCF-7.40
Earnings Yield-10.99%
FCF Yield-9.95%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio9.05
Quick Ratio9.05
Target$20.00
Target Upside225.20%
Target Median$20.00
Target Range20.00 - 20.00
Volume834.83K
Avg Volume931.04K
EPS Surprise-0.05
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
63/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 9.05Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-04
94/100
Bullish
Bullish
7
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$20.00
Mean
$20.00
Median
$20.00
High
$20.00
Insider Transactions
Recent executive and insider activity
Eisner Mark
Transaction: 06/17/2026
BUY
Change
+51,000
Price
$3.62
Filing
06/22/2026
Type
BUY
Munshi Amit
Transaction: 06/17/2026
BUY
Change
+51,000
Price
$3.62
Filing
06/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Becker Daniel J. | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Eisner Mark | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Munshi Amit | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Nirula Ajay | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Schoch Steven J | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Thiara Parvinder | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Jarrett Jennifer | BUY | +51,000 | $3.62 | 06/17/2026 | 06/22/2026 |
| Mathew Marlyn Teresa | OTHER | +66,220 | $6.03 | 04/17/2026 | 06/22/2026 |
| Mathew Marlyn Teresa | OTHER | 0 | Not reported | 04/17/2026 | 06/22/2026 |
| Kulkarni Sandeep Chidambar | BUY | +894,000 | $6.03 | 04/01/2026 | 04/02/2026 |
| Davis Kim | BUY | +425,700 | $6.03 | 04/01/2026 | 04/02/2026 |
| Hyllengren Eric J | BUY | +340,900 | $6.03 | 04/01/2026 | 04/02/2026 |
| Nistala Kiran | BUY | +340,900 | $6.03 | 04/01/2026 | 04/02/2026 |
| Whale Gary | BUY | +263,000 | $6.03 | 04/01/2026 | 04/02/2026 |
| Nirula Ajay | OTHER | 0 | Not reported | 02/21/2026 | 03/05/2026 |
| Nirula Ajay | BUY | +37,812 | $6.53 | 02/21/2026 | 03/05/2026 |
| AI Biotechnology LLC | BUY | +2,000,000 | $6.25 | 02/26/2026 | 03/02/2026 |
| Eisner Mark | OTHER | 0 | Not reported | 02/21/2026 | 02/24/2026 |
| Eisner Mark | BUY | +37,812 | $6.53 | 02/21/2026 | 02/24/2026 |
| Thiara Parvinder | OTHER | +48,149 | $3.98 | 01/23/2026 | 01/27/2026 |